Novavax, Inc.
(NASDAQ : NVAX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 1.31%138.040.0%$905.67m
AMGNAmgen, Inc. 1.06%250.131.5%$837.76m
GILDGilead Sciences, Inc. 0.43%64.111.0%$544.30m
VRTXVertex Pharmaceuticals, Inc. 4.27%269.641.9%$481.69m
REGNRegeneron Pharmaceuticals, Inc. 3.58%684.812.6%$437.21m
ILMNIllumina, Inc. 1.18%246.373.3%$317.51m
NVAXNovavax, Inc. -1.14%52.8175.7%$304.00m
BIIBBiogen, Inc. 0.63%200.901.8%$241.55m
BNTXBioNTech SE 0.61%164.000.0%$227.80m
SNSSSunesis Pharmaceuticals, Inc. 0.00%2.110.7%$147.50m
EXASEXACT Sciences Corp. -1.41%52.4217.7%$145.01m
TXG10X Genomics, Inc. -0.98%49.670.0%$100.30m
TECHBio-Techne Corp. -0.56%364.304.5%$100.23m
NKTXNkarta, Inc. 0.87%12.780.0%$100.13m
BMRNBioMarin Pharmaceutical, Inc. 1.29%80.754.2%$99.68m

Company Profile

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.